Alpha Teknova, Inc. Common Stock

TKNO XNAS IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Market Cap

280M

Short interest (May 15)

2.4%

Net Short (Jun 03 ): 0.0%

Borrow Fee

0.80%

↑ 68.7%

Available Shares

300K

↓ 43.2%

Price Chart

Company Overview

Alpha Teknova Inc is a producer of critical reagents for the discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics. Its offer two primary product categories: Lab Essentials and Clinical Solutions. It derives key revenue from the United States. The company offers three primary product types: (i) pre-poured media plates for cell growth and cloning; (ii) liquid microbial culture media and supplements for cellular expansion; and (iii) molecular biology reagents for sample manipulation, resuspension, and purification.

Company Info

Exchange: NASDAQ
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
CIK: 0001850902
Asset Type: CS

Market Data

Market Cap: $277,720,665
Employees: 158
Status: Active

Short Interest

Current Borrow Fee 0.80%
Range: 0.67% - 0.89%
Available Shares 300K
Range: 150K - 250K

Recent Changes

Fee Change: ↓ 21.4%
Available Change: ↑ 14.3%

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime